Jiangxi Fushine Pharmaceutical Co.,Ltd. Posted 92.9 Million Yuan Net Loss in First Three Quarters of 2023

Jiangxi Fushine Pharmaceutical Co.,Ltd. (江西富祥药业股份有限公司) (300497.SZ) reported a net loss of 92.9 million yuan in the first three quarters of 2023, reversing a net profit of 27.6 million yuan for the same period in the previous year.

Meanwhile, the company posted 1.3 billion yuan in revenue, up 4.4% year-on-year.

At the end of the reporting period, it had 4.9 billion yuan in total assets and 2.3 billion yuan in total liabilities, with a liability-to-asset ratio of 47.4%.